{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Diseases&page=10", "query": { "condition": "Congenital Diseases", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 10529, "total_pages": 1053, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Diseases&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Diseases&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T14:31:40.528Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06100887", "title": "Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Duchenne Muscular Dystrophy" ], "interventions": [ { "name": "Sevasemten Dose 1", "type": "DRUG" }, { "name": "Sevasemten Dose 2", "type": "DRUG" }, { "name": "Sevasemten Dose 3", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Edgewise Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "MALE", "summary": "6 Years to 17 Years · Male only" }, "enrollment_count": 43, "start_date": "2024-03-22", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2025-11-06", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 7, "location_summary": "Los Angeles, California • Sacramento, California • Gainesville, Florida + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Worcester", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06100887" }, { "nct_id": "NCT03993821", "title": "Burosumab for CSHS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)", "Epidermal Nevus Syndrome" ], "interventions": [ { "name": "Burosumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Laura Tosi", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1, "start_date": "2019-07-01", "completion_date": "2026-03-03", "has_results": false, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03993821" }, { "nct_id": "NCT03487367", "title": "Clinical Trial Readiness for SCA1 and SCA3", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia 3" ], "interventions": [], "intervention_types": [], "sponsor": "The Methodist Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 200, "start_date": "2018-08-16", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2022-01-19", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03487367" }, { "nct_id": "NCT01252264", "title": "FaceBase Biorepository", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Craniofacial Abnormalities", "Cleft Lip", "Cleft Palate" ], "interventions": [], "intervention_types": [], "sponsor": "Jeff Murray", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "125 Years", "sex": "ALL", "summary": "Up to 125 Years" }, "enrollment_count": 5000, "start_date": "2010-11", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2018-05-04", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01252264" }, { "nct_id": "NCT05295732", "title": "The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ichthyosis" ], "interventions": [ { "name": "TMB-001", "type": "DRUG" }, { "name": "Matching Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 153, "start_date": "2022-06-21", "completion_date": "2024-09-23", "has_results": true, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 18, "location_summary": "Phoenix, Arizona • Palo Alto, California • Centennial, Colorado + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05295732" }, { "nct_id": "NCT00384163", "title": "Adult Pulmonary Valve Replacement: A Simple and Reproducible Technique", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Congenital Disorders" ], "interventions": [], "intervention_types": [], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2007-08", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2013-11-26", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00384163" }, { "nct_id": "NCT04009187", "title": "A Wheelchair Propulsion Training Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries", "Multiple Sclerosis", "Amputation", "Spina Bifida" ], "interventions": [ { "name": "In-person wheelchair propulsion training program", "type": "BEHAVIORAL" }, { "name": "30-minute education session", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2018-03-27", "completion_date": "2019-10-22", "has_results": false, "last_update_posted_date": "2025-03-28", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04009187" }, { "nct_id": "NCT00268021", "title": "Automated Cardioverter Defibrillator in Children", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Congenital Disorders" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Healthcare of Atlanta", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 34, "start_date": "1998-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-12-02", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00268021" }, { "nct_id": "NCT00074516", "title": "Kidney Transplantation in Patients With Cystinosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cystinosis" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 11, "start_date": "2003-12-10", "completion_date": "2014-06-11", "has_results": false, "last_update_posted_date": "2017-10-06", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00074516" }, { "nct_id": "NCT07591584", "title": "A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "IBS (Irritable Bowel Syndrome)", "Bloating", "Abdominal Pain", "Gut Health" ], "interventions": [ { "name": "FODMAP-targeting digestive enzyme blend", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Kiwi Health Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2026-05-04", "completion_date": "2026-10-26", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-10-14T14:31:40.528Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07591584" } ] }